Nachrichten zur Bristol-Myers Squibb Co. Aktie

Bristol-Myers Squibb: Großes Interesse an ADC-Playern - Tubulis holt hochkarätige Investoren an Bord - Aktienanalyse

Kulmbach (www.aktiencheck.de) - Bristol-Myers Squibb-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt die Aktie von Bristol-Myers Squibb Company…

Bristol-Myers Squibb Company (BMY) Management Presents at Leerink Partners Global Biopharma Conference 2024 Conference (Transcript)

…

Bristol Myers, Moderna und Roche ziehen Anti Virus-Index auf Jahreshoch

Der Global Anti Virus Health Net Return Index hat in den zurückliegenden Tagen von der Mehrheit der Indexmitglieder Rückenwind erhalten.…

Societe Generale cuts Bristol-Myers Squibb to Hold By Investing.com

Societe Generale cuts Bristol-Myers Squibb to Hold…

Bristol-Myers Squibb: Finally Trending Up

…

Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024, Featuring Sanofi, Bristol Myers Squibb, Abbott Laboratories, Takeda Pharmaceutical and Amgen

Dublin, March 08, 2024 (GLOBE NEWSWIRE) -- The "Chemotherapy Induced Peripheral Neuropathy Treatment Global Market Report 2024" has…

Bristol-Myers Squibb: Turnaround Expected

…

Bristol-Myers Squibb: Compelling Value From The New Products Portfolio And 4.5% Yield

…

Bristol-Myers Squibb Company (BMY) 44th Annual TD Cowen Healthcare Conference (Transcript)

…

Follicular Lymphoma Market to Witness Upsurge in Growth by 2032, Predicts DelveInsight | Key Companies - AbbVie, Genmab, Novartis, Allogene Therapeutics, Pfizer, Genentech, Incyte Corporation, Bristol-Myers Squibb

The dynamics of the follicular lymphoma market are anticipated to change in the coming years owing to the improvement in…

Bristol Myers Squibb completes RayzeBio acquisition By Investing.com

Bristol Myers Squibb completes RayzeBio acquisition…

dpa-AFX ProFeed